Preclinical Research & Case Studies

Mechanism: Corresponds to the actin-binding region (LKKTETQ) of Thymosin Beta-4, a regenerative protein in most cell types. The literature links it to G-actin regulation, cell migration, and angiogenesis (VEGF, HIF-1α).

• Bock-Marquette et al. (2004), Nature (432:466–472): A landmark study reporting that Thymosin Beta-4 activated integrin-linked kinase, promoted cardiac cell migration and survival, and supported cardiac repair after simulated myocardial infarction (reducing infarct size in mice).
  Model: Mouse myocardial-infarction model | Source →
• Malinda, Goldstein & Kleinman (1997), FASEB Journal: Established that Thymosin Beta-4 stimulates directed migration of human umbilical-vein endothelial cells — the mechanistic foundation for subsequent angiogenesis research.
  Model: Human endothelial cell culture (in vitro) | Source →
• Philp, Goldstein & Kleinman (2004), Mechanisms of Ageing and Development (125:113–115): Reported that Thymosin Beta-4 promotes angiogenesis, wound healing, and hair-follicle development; related work showed accelerated corneal re-epithelialization with reduced ocular-surface inflammation and faster dermal wound healing in rats.
  Model: Rat / mouse wound and ocular models | Source →
• Gao et al. (2015), PLoS One: Using Tβ4-overexpressing and knockout mice, hair regrew faster in overexpressing mice (more follicles entering anagen, more shafts) and slower in knockouts, with elevated VEGF and P38/ERK/AKT signaling — evidence that normal Tβ4 is required for typical hair cycling.
  Model: Transgenic and knockout mouse hair models | Source →

Research stage: Most mechanism work uses the full 43-amino-acid Tβ4 protein; no completed human efficacy trial of the TB-500 fragment has been published.